GAMMAGARD LIQUID
[Immune Globulin Intravenous (Human)]
and
GAMMAGARD S/D
[Immune Globulin Intravenous (Human)]
GAMMASSIST
Peace of mind during insurance coverage lapses. Find out more about the GAMMASSIST program.
The GARDian program helps ensure patients' continued access to GAMMAGARD therapy.
GARDian is an innovative Baxter program designed to help provide continued access to GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% for current patients. Enrolling your patients in GARDian is a simple, secure way to ensure their continued access to GAMMAGARD, their choice of treatment, when they change physician, site of care, or residence.
Request Your New Patient Starter Kit
A helpful guide to PI and
IVIG, with tips for healthy
living.
Sign Up for our Newsletter
We'll keep you updated
so you won't miss out
on any new additions
PI Panel - Questions about Plasma Safety?
Ask a question to Baxter’s Director of Global Pathogen Safety or other members of the PI panel.
GAMMAGARD LIQUID is indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies.
Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10%
GAMMAGARD S/D and GAMMAGARD S/D, IgA less than 1 µg/mL in a 5% solution are indicated for the treatment of primary immunodeficiency disorders associated with defects in humoral immunity. These include but are not limited to congenital X-linked agammaglobulinemia, common variable immunodeficiency, Wiskott-Aldrich syndrome, and severe combined immunodeficiencies. GAMMAGARD S/D must not be used in patients with selective IgA deficiency (IgA < 0.05 g/L) where the IgA deficiency is the only abnormality of concern.
Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)]
Please see the Important Safety Information and Full Prescribing Information for GAMMAGARD S/D [Immune Globulin Intravenous (Human)], IgA less than 1 µg/mL in a 5% solution.
 To view PDFs, you will need
Adobe® Acrobat® Reader® software.
|
